Cenobamate (ONTOZRY®), for the Treatment of Uncontrolle

Cenobamate use results in unprecedented seizure freedom rates for patients 1PARIS--(BUSINESS WIRE)--Angelini Pharma, international pharmaceutical company part of the privately held Italian Angelini Group, today announced that ONTOZRY® (cenobamate) is now available in France and Belgium for the adjunctive treatment o...

Related Keywords

Germany , Norway , Hungary , Denmark , Netherlands , United Kingdom , Belgium , Geneva , Genè , Switzerland , Italy , Sweden , Austria , France , Northern Ireland , Craigavon , Italian , French , Angelini Pharma , Global Campaign Against Epilepsy , Angelini Industries , European Union , World Health Organization , Italian Angelini Group , Brain Health , European Medicines Agency , About Angelini , European Economic Area , Finland Netherlands , Slovakia Spain , Campaign Against Epilepsy , Indian Acad , Epilepsy Curr , Eurj Neurosci ,